Search

everythinglearnresearchcommunity

for

Search:↓

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

People with severe alopecia areata often have lower vitamin D levels and may have other autoimmune or allergic conditions.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

The document suggests that certain protein deficiencies and scalp blistering in Epidermolysis Bullosa may cause hair loss.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

In a Tuscan pediatric clinic, 7.19% of children had hair or scalp disorders, with nonscarring alopecia being the most common.

Children's hair loss can be caused by many factors, including autoimmune diseases, emotional stress, genetics, and infections, with treatment and prognosis varying.

CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Heat treatment increases hair loss in certain mice.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

White hair regrowth in alopecia areata may be more common than thought.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

BST2 protein and certain T cells increase in early alopecia areata.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Trichoscopy helps diagnose and track alopecia areata by examining specific hair and scalp markers.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

The document provides a comprehensive guide for dermatologists to diagnose and treat hair loss.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.